GENB

Generate Biomedicines INC

+$1.2B

Net Activity

Institutions Holding

57

Popularity Rank

#5675

Avg Weight

1.72%

Total Value

$1.2B

Ownership Trend

57 institutions currently hold GENB, with 56 net buyers and 0 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Significantly Increased

Based on recent trading activity

Net Selling Institutions

0

Net Buying Institutions

56

Key Holders

View all 57 holding institutions

Quarterly Activity

Recent Activity

+$1.2B

Total Buy Value

$0.0

Total Sell Value

New buy56
Trim0
Add0
Sold out0

56

Net Buyers

0

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding GENERATE BIOMEDICINES INC (GENB)?
Major stakeholders currently include Flagship Pioneering, LLC ($783.4M), FMR LLC ($52.7M), Capital World Investors ($50.1M). Based on the latest 13F filings, there are a total of 57 tracked investment funds and institutions maintaining positions in GENB.
What is the overall institutional sentiment toward GENB recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $1.2B, driven by 56 managers accumulating shares while 0 reduced their exposure.
Which institutions have been selling or reducing their GENB positions?
In the latest period, no tracked funds trimmed or exited their positions in GENB.
Are there any notable investors adding GENB to their portfolios?
Yes, buying activity remains notable. 56 institutions opened new positions in {ticker}, and 0 existing holders added to their shares. The total reported buy value for the quarter amounted to $1.2B.

Related Stocks